ATE176231T1 - Triazin-derivate, verfahren zu ihrer herstellung und ihre verwendung - Google Patents

Triazin-derivate, verfahren zu ihrer herstellung und ihre verwendung

Info

Publication number
ATE176231T1
ATE176231T1 AT94116173T AT94116173T ATE176231T1 AT E176231 T1 ATE176231 T1 AT E176231T1 AT 94116173 T AT94116173 T AT 94116173T AT 94116173 T AT94116173 T AT 94116173T AT E176231 T1 ATE176231 T1 AT E176231T1
Authority
AT
Austria
Prior art keywords
atom
oxygen
group
bound
hydrogen atom
Prior art date
Application number
AT94116173T
Other languages
English (en)
Inventor
Hideki Miki
Koichi Iwanaga
Toshimi Matsuno
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE176231T1 publication Critical patent/ATE176231T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
AT94116173T 1993-10-15 1994-10-13 Triazin-derivate, verfahren zu ihrer herstellung und ihre verwendung ATE176231T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25865493 1993-10-15
JP22376194 1994-09-19

Publications (1)

Publication Number Publication Date
ATE176231T1 true ATE176231T1 (de) 1999-02-15

Family

ID=26525666

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94116173T ATE176231T1 (de) 1993-10-15 1994-10-13 Triazin-derivate, verfahren zu ihrer herstellung und ihre verwendung

Country Status (13)

Country Link
EP (1) EP0648760B1 (de)
KR (1) KR100346128B1 (de)
CN (1) CN1062861C (de)
AT (1) ATE176231T1 (de)
BR (1) BR9404113A (de)
CA (1) CA2118193A1 (de)
DE (1) DE69416235T2 (de)
DK (1) DK0648760T3 (de)
ES (1) ES2126693T3 (de)
GR (1) GR3029856T3 (de)
MY (1) MY111486A (de)
RU (1) RU2146674C1 (de)
TW (1) TW403741B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994355A (en) 1993-10-15 1999-11-30 Takeda Chemical Industries, Ltd. 1, 2, 4-Triazin-3-one derivatives, production and use thereof
DE69615601T2 (de) * 1995-04-14 2002-07-11 Takeda Schering-Plough Animal Health K.K., Osaka Verfahren zur Herstellung von Triazinderivate
US5985875A (en) * 1996-08-30 1999-11-16 Takeda Chemical Industries, Ltd. 1,2,4-triazine-3, 5-dione derivatives, their production and use thereof
US6867207B2 (en) 1997-07-10 2005-03-15 Janssen Pharmaceutica N.V. IL-5 inhibiting 6-azauracil derivatives
CA2294145A1 (en) * 1997-07-10 1999-01-21 Janssen Pharmaceutica N.V. Il-5 inhibiting 6-azauracil derivatives
WO1999011634A1 (en) 1997-08-29 1999-03-11 Takeda Chemical Industries, Ltd. Triazine derivatives, their production and use
KR100635721B1 (ko) 1998-12-18 2006-10-17 얀센 파마슈티카 엔.브이. Il-5 억제성 6-아자우라실 유도체
MXPA03003707A (es) * 2000-10-27 2004-05-04 Dow Agrosciences Llc 4,5-dihidro-1,2,4-triazin-3-onas, 1,2,4-triazin-3-onas y su uso como fungicidas e insecticidas.
PA8591801A1 (es) * 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
ES2524922T3 (es) 2005-05-10 2014-12-15 Intermune, Inc. Derivados de piridona para modular el sistema de proteína cinasa activada por estrés
JP5627574B2 (ja) 2008-06-03 2014-11-19 インターミューン, インコーポレイテッド 炎症性および線維性疾患を治療するための化合物および方法
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CN103497193B (zh) * 2013-09-25 2015-09-02 武汉大学 具有1,2,4-三嗪骨架结构的衍生物及其合成方法
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.
AU2019351944A1 (en) * 2018-10-01 2021-04-15 Pi Industries Ltd Oxadiazoles as fungicides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2532363A1 (de) * 1975-07-19 1977-02-03 Bayer Ag Substituierte 2-phenyl-1,2,4- triazin-3,5(2h,4h)-dione, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2606850A1 (de) * 1976-02-20 1977-09-15 Hoechst Ag Substituierte p-aminophenyl-as- triazindione und ihre herstellung
CH628349A5 (en) * 1977-10-21 1982-02-26 Pfizer Thiazol derivatives and anthelmintic medicament containing them
DE3408924A1 (de) * 1984-03-12 1985-09-26 Hoechst Ag, 6230 Frankfurt Substituierte 2-phenyl-hexahydro-1,2,4-triazin-3,5-dione, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
AU578708B2 (en) * 1984-06-12 1988-11-03 Fmc Corporation Herbicidal 2-aryl-1,2,4-triazine-3,5(2h,4h)-diones and sulfuranalogs thereof
US4631278A (en) * 1984-08-01 1986-12-23 Janssen Pharmaceutica N.V. Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
CN1044905A (zh) * 1989-02-16 1990-08-29 赫彻斯特股份公司 鱼和昆虫寄生虫对抗剂
DE4030042A1 (de) * 1990-05-17 1991-11-21 Bayer Ag Verwendung von substituierten 1,2,4-triazindionen
EP0476439A1 (de) * 1990-09-18 1992-03-25 Bayer Ag Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung

Also Published As

Publication number Publication date
KR100346128B1 (ko) 2002-11-23
KR950011420A (ko) 1995-05-15
EP0648760A3 (de) 1995-06-28
CN1062861C (zh) 2001-03-07
EP0648760A2 (de) 1995-04-19
GR3029856T3 (en) 1999-07-30
CA2118193A1 (en) 1995-04-16
ES2126693T3 (es) 1999-04-01
DE69416235D1 (de) 1999-03-11
RU2146674C1 (ru) 2000-03-20
BR9404113A (pt) 1995-06-27
MY111486A (en) 2000-06-30
EP0648760B1 (de) 1999-01-27
CN1106394A (zh) 1995-08-09
DE69416235T2 (de) 1999-09-30
TW403741B (en) 2000-09-01
RU94036760A (ru) 1996-08-10
DK0648760T3 (da) 1999-09-13

Similar Documents

Publication Publication Date Title
ATE176231T1 (de) Triazin-derivate, verfahren zu ihrer herstellung und ihre verwendung
ATE123771T1 (de) Stickstoff enthaltende heterozyklische verbindungen, ihre herstellung und verwendung.
DE69025941D1 (de) Dem Physostigmin verwandte 4- und 6-Carbamate, ein Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE69923300D1 (de) Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung
DE69430636D1 (de) Neue imidazol-derivate und verfahren zu deren herstellung
ATE137805T1 (de) Verfahren zur erhöhung von chemilumineszenz
DE3576955D1 (de) Beta-carbolin-3-oxadiazolylderivate, verfahren zu ihrer herstellung und ihre verwendung.
PT77924B (de) Disubstituierte prolinderivate verfahren zu ihrer herstellung und ihre verwendung
DE69118470D1 (de) Substituierte 4-amino-3-pyridinolen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE69202120D1 (de) Harnstoffderivate, ihre Herstellung und ihre Verwendung bei der Therapie.
DE3578178D1 (de) Beta-carbolin-3-carbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung.
ATE223925T1 (de) 2,2'-disubstituierte 1,1'-diphosphino-ferrocene und 1',2-disubstituierte 1-phosphino-ferrocene, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende übergangsmetallkomplexe
DE68902386D1 (de) N-pyridinyl-9h-carbazol-9-amine, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
ATE261441T1 (de) Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
DE69125569D1 (de) 8-Azabicyclo[3.2.1]octylalkylthiazolidinone, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE69131546D1 (de) Pyrido[3,4-b]pyrrolo[1,2-e][1,4,5]oxadiazepine und verwandte Analoge, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
BR9600979A (pt) Composto processo para combater fungos fitopatogênicos composição fungicida e processo de preparação de um composto
DE68907857D1 (de) Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE315561T1 (de) Carbamatderivate, verfahren zu deren herstellung und deren verwendung
DE3669157D1 (de) Alpha-allylierte arylalkyltriazole, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
DE69924636D1 (de) Verfahren zur herstellung von chiralen derivaten
DE69210648D1 (de) 1,2,4-Triazolo[1,5-a]pyrimidinderivate, Verfahren zu ihrer Herstellung, diese enthaltende Arzneimittel und ihre Verwendung
GEP19970838B (en) Process for obtaining 3-(methyltio, methylsulphinyl or methylsulphonyl)-4-quinolone

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee